Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Recent Articles
- North Alabama Mountain Lakes: A New Standard for Access in Travel
- Western Uranium Secures $5 Million Financing for Growth Initiatives
- Dazzling Gold Ball Ignites Newark Arts Festival 2025 Celebration
- Investors Rally: Unicycive Therapeutics Class Action Opportunity
- S-Tron Shanghai 2025: A Milestone Event for Innovation Growth
- Investors' Urgent Notice on KBR Class Action Lawsuits
- Molina Healthcare Faces Class Action Lawsuits – Act Now!
- V.F. Corporation Faces Class Action Lawsuit Amid Huge Losses
- KinderCare Investors: Important Class Action Deadline Overview
- Legal Deadlines Approaching for Fluor Corporation Investors
- Important Legal Action for Molina Healthcare Investors Ahead
- Jensen Huang's Insights on AMD's Strategic Move With OpenAI
- Kathy Yang Earns Spot Among Asia's Most Powerful Women 2025
- Snap Inc. Investors Urged to Act: Lead Plaintiff Deadline Approaching
- Apogee Therapeutics' Strategic Move in Public Offering
- Investors Urged to Act Ahead of Dow Inc. Lawsuit Deadline
- C3.ai Investors: Important Class Action Lawsuit Update
- Cytokinetics Investors Urged to Take Action Amid Legal Battle
- Bitcoin and Dogecoin Surging Amid Market Changes
- Kathy Yang Recognized as a Leading Business Figure in Asia
- Neopharma Technologies Welcomes Joo Seng Wong as Advisor
- Fireblocks and Moomoo Team Up to Enhance Digital Investment
- Forecast for Semiconductor Equipment Spending Until 2028
- Apogee Therapeutics Launches $300 Million Public Stock Offering
- Key Developments Driving Costco, AMD, Recursion, Cipher Mining & Snowflake
- Live Nation Entertainment's Strategic Move with Convertible Notes
- Fossil Group Reveals Details About Its Restructuring Plan
- MrBeast's Journey from Chaos to a Multi-Billion Dollar Empire
- Cartier Silver Secures $1.5 Million for Expansion Initiatives
- Fossil Group Outline Restructuring Plans at Upcoming Hearing
- Fosun International Achieves 72 on Sustainability Scorecard
- Community Activists Unite Against Airbnb for Responsibility
- Fosun International Achieves New Heights in Sustainability Rankings
- Maximizing Revenue Through Innovative Automation Strategies
- Cartier Silver Partners with Centurion One to Boost Investment
- Volcan Compañía Minera Initiates Cash Tender Offer for Notes
- Farizon SV Recognized for International Van of the Year Honor
- Trump Celebrates Signed Peace Agreement Between Israel and Hamas
- Voyageur Mineral Explorers Updates Shareholders on Meeting Plans
- Brookfield Residential Announces Q3 2025 Conference Call Details
- Farizon SV Earns Spot in International Van of the Year Awards
- Credit Unions Provide Vital Support Amid Financial Uncertainty
- Key Developments for Voyageur Mineral Explorers Corp. Announced
- ColorTokens Achieves PROTECTED Level in Cybersecurity Assessment
- Recognizing Corporate Excellence: 347 Leaders Honored for 2024
- Gaming Laboratories International Expands Security Framework Offerings
- Investigation into Encompass Health: A Comprehensive Overview
- How Your $1000 Investment in Chevron Would Have Grown
- Unlocking Future Growth: Jovay Integrates Chainlink's Advanced Solutions
- ProCure Proton Therapy Advocates for Early Breast Cancer Awareness